![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology](https://www.science.org/cms/asset/d02c5338-95d1-468e-9dc0-9bdc83d158ba/keyimage.gif)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abl4340/asset/73469e46-673e-457e-a611-01f596f0d533/assets/images/large/sciimmunol.abl4340-f1.jpg)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology
![JPM | Free Full-Text | Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis JPM | Free Full-Text | Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis](https://www.mdpi.com/jpm/jpm-12-00252/article_deploy/html/images/jpm-12-00252-g001-550.jpg)